Steven TrimFounder and Chief Scientific Officer at Venomtech Limited
Profile
Ten years as a drug discovery biologist at Pfizer focusing on pain and neuroscience, then post redundancy, incorporated Venomtech to deliver venom based, targeted screening arrays for drug discovery in 2010. Ten years on, Venomtech are still delivering venom peptide hits, from echo compatible screening libraries on a wide range of drug discovery targets for a global customer base.
Agenda Sessions
Peptides Derived from Natural Products
12:15View SessionVenom-derived Screening Tools as Sources for Novel Leads
On DemandView Session